Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Tissue Engineering and Regenerative Medicine ; (6): 653-665, 2017.
Artigo em Inglês | WPRIM | ID: wpr-657088

RESUMO

Liver failure is one of the main risks of death worldwide, and it originates from repetitive injuries and inflammations of liver tissues, which finally leads to the liver cirrhosis or cancer. Currently, liver transplantation is the only effective treatment for the liver diseases although it has a limitation due to donor scarcity. Alternatively, cell therapy to regenerate and reconstruct the damaged liver has been suggested to overcome the current limitation of liver disease cures. Several transplantable cell types could be utilized for recovering liver functions in injured liver, including bone marrow cells, mesenchymal stem cells, hematopoietic stem cells, macrophages, and stem cell-derived hepatocytes. Furthermore, paracrine effects of transplanted cells have been suggested as a new paradigm for liver disease cures, and this application would be a new strategy to cure liver failures. Therefore, here we reviewed the current status and challenges of therapy using stem cells for liver disease treatments.


Assuntos
Humanos , Células da Medula Óssea , Terapia Baseada em Transplante de Células e Tecidos , Células-Tronco Hematopoéticas , Hepatócitos , Inflamação , Cirrose Hepática , Hepatopatias , Falência Hepática , Regeneração Hepática , Transplante de Fígado , Fígado , Macrófagos , Células-Tronco Mesenquimais , Transplante de Células-Tronco , Células-Tronco , Doadores de Tecidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA